Virologic Outcomes and Adherence to Treatment Algorithms in a Longitudinal Study of Patients with Chronic Hepatitis C Treated with Boceprevir (BOC) or Telaprevir (TVR) in the United States (HCV-TARGET)
Publication
, Conference
Di Bisceglie, AM; Kuo, A; Rustgi, VK; Sulkowski, MS; Sterling, RK; Stewart, T; Fried, MW; Fenkel, JM; ElGenaidi, H; Mah'moud, MA; Abraham, GM
Published in: HEPATOLOGY
October 1, 2013
Duke Scholars
Published In
HEPATOLOGY
EISSN
1527-3350
ISSN
0270-9139
Publication Date
October 1, 2013
Volume
58
Start / End Page
227A / 228A
Location
Washington, DC
Publisher
WILEY-BLACKWELL
Conference Name
64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases
Related Subject Headings
- Gastroenterology & Hepatology
- 3204 Immunology
- 3202 Clinical sciences
- 1107 Immunology
- 1103 Clinical Sciences
- 1101 Medical Biochemistry and Metabolomics
Citation
APA
Chicago
ICMJE
MLA
NLM
Di Bisceglie, A. M., Kuo, A., Rustgi, V. K., Sulkowski, M. S., Sterling, R. K., Stewart, T., … Abraham, G. M. (2013). Virologic Outcomes and Adherence to Treatment Algorithms in a Longitudinal Study of Patients with Chronic Hepatitis C Treated with Boceprevir (BOC) or Telaprevir (TVR) in the United States (HCV-TARGET). In HEPATOLOGY (Vol. 58, pp. 227A-228A). Washington, DC: WILEY-BLACKWELL.
Di Bisceglie, Adrian M., Alexander Kuo, Vinod K. Rustgi, Mark S. Sulkowski, Richard K. Sterling, Thomas Stewart, Michael W. Fried, et al. “Virologic Outcomes and Adherence to Treatment Algorithms in a Longitudinal Study of Patients with Chronic Hepatitis C Treated with Boceprevir (BOC) or Telaprevir (TVR) in the United States (HCV-TARGET).” In HEPATOLOGY, 58:227A-228A. WILEY-BLACKWELL, 2013.
Di Bisceglie AM, Kuo A, Rustgi VK, Sulkowski MS, Sterling RK, Stewart T, et al. Virologic Outcomes and Adherence to Treatment Algorithms in a Longitudinal Study of Patients with Chronic Hepatitis C Treated with Boceprevir (BOC) or Telaprevir (TVR) in the United States (HCV-TARGET). In: HEPATOLOGY. WILEY-BLACKWELL; 2013. p. 227A-228A.
Di Bisceglie, Adrian M., et al. “Virologic Outcomes and Adherence to Treatment Algorithms in a Longitudinal Study of Patients with Chronic Hepatitis C Treated with Boceprevir (BOC) or Telaprevir (TVR) in the United States (HCV-TARGET).” HEPATOLOGY, vol. 58, WILEY-BLACKWELL, 2013, pp. 227A-228A.
Di Bisceglie AM, Kuo A, Rustgi VK, Sulkowski MS, Sterling RK, Stewart T, Fried MW, Fenkel JM, ElGenaidi H, Mah’moud MA, Abraham GM. Virologic Outcomes and Adherence to Treatment Algorithms in a Longitudinal Study of Patients with Chronic Hepatitis C Treated with Boceprevir (BOC) or Telaprevir (TVR) in the United States (HCV-TARGET). HEPATOLOGY. WILEY-BLACKWELL; 2013. p. 227A-228A.
Published In
HEPATOLOGY
EISSN
1527-3350
ISSN
0270-9139
Publication Date
October 1, 2013
Volume
58
Start / End Page
227A / 228A
Location
Washington, DC
Publisher
WILEY-BLACKWELL
Conference Name
64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases
Related Subject Headings
- Gastroenterology & Hepatology
- 3204 Immunology
- 3202 Clinical sciences
- 1107 Immunology
- 1103 Clinical Sciences
- 1101 Medical Biochemistry and Metabolomics